FDA Adverse Event Malfunction Summary report: N

DIMENSION(R) CLINICAL CHEMISTRY SYSTEM

MDR report key: 4142602 · Received October 6, 2014

Report

Report Number
2517506-2014-00224
Event Type
Malfunction
Date Received
October 6, 2014
Date of Event
May 22, 2014
Report Date
September 15, 2014
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
Product Code
LCP
PMA / PMN Number
K102510
Removal / Correction Number
2517506-10-03-2014-008-C
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
KS, US
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Additional Manufacturer Narrative · 1

SIEMENS HEALTHCARE DIAGNOSTICS HAS CONFIRMED THAT THE DIMENSION® (B)(6) FLEX® REAGENT CARTRIDGE LOTS GA4266, BA4273, BA4280, BA4287, GA4301, GA4315, GC4322, GA4343, GA4350, GA4357, GA5013, AND GA5020 EXHIBIT A POSITIVE BIAS AVERAGING 0.4% HEMOGLOBIN A1C UNITS AND OCCASIONALLY UP TO 1.0% (B)(6)UNITS FOR PATIENT SAMPLES WHEN COMPARED TO THE NATIONAL GLYCOHEMOGLOBIN STANDARDIZATION PROGRAM (NGSP). QC SAMPLES MAY EXHIBIT A SIMILAR BIAS. THIS BIAS RESULTED IN COMPLAINTS FOR (B)(6) SURVEY FAILURES. IN THE URGENT MEDICAL DEVICE RECALL LETTER DATED (B)(4) 2014, #14-60 ISSUED TO CUSTOMERS WHO WERE SHIPPED THE IMPACTED LOTS, SIEMENS DIRECTED CUSTOMERS TO DISCONTINUE USE AND TO DISCARD THE IMPACTED LOTS. SIEMENS STATED IT WOULD REPLACE ANY UNUSED INVENTORY OF THE AFFECTED LOTS AT NO CHARGE WITH A NON-AFFECTED LOT.

Description of Event or Problem · 1

BIASED (B)(6) RESULTS WERE OBTAINED ON (B)(6) SURVEY SAMPLES. IT IS UNKNOWN IF PATIENT TREATMENT WAS ALTERED OR PRESCRIBED ON THE BASIS OF THE BIASED (B)(6) RESULTS. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES AS A RESULT OF THE BIASED (B)(6) RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
624351 DIMENSION(R) CLINICAL CHEMISTRY SYSTEM HEMOGLOBIN A1C KIT LCP SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW GA4343

Patients

Seq Age Sex Outcome Treatment
1 Disability